FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to medicine. Pharmaceutical composition containing nicotinic acid, nicotinamide, tryptophan or related compounds for positively influencing the intestinal microbiota is described.
EFFECT: pharmaceutical composition is partially or entirely released into the small intestine or large intestine for positively influencing the intestinal microbiota.
20 cl, 7 dwg, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF MICROBIAL COMMUNITIES FOR THE TREATMENT OF HUMANS AND ANIMALS | 2017 |
|
RU2758387C2 |
| USE OF MICROBIAL COMMUNITIES FOR TREATING HUMANS AND ANIMALS | 2017 |
|
RU2823233C2 |
| COP1 FOR TREATMENT OF INFLAMMATORY DISEASES OF INTESTINE | 2004 |
|
RU2339397C2 |
| PROBIOTIC COMPOSITION FOR APPLICATION IN TREATMENT OF INTESTINAL INFLAMMATION | 2011 |
|
RU2563525C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | 2017 |
|
RU2738114C2 |
| APPLICATION OF BIFIDOBACTERIUM LONGUM IN PRODUCTION OF MEDICINAL AGENT OR THERAPEUTIC NUTRIENT COMPOSITION FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE IN MAMMAL AND FOR SUPPRESSION OF BOWEL INFLAMMATION RELATED TO FOOD ALLERGENS, IN MAMMAL | 2007 |
|
RU2445362C2 |
| STRAIN LACTOBACILLUS GASSERI KBL697 AND ITS USE | 2019 |
|
RU2798872C2 |
| METHODS FOR MODULATING INTESTINAL MICROBIOTA | 2017 |
|
RU2738265C2 |
| POLYSACCHARIDE FROM Bifidobacterium infantis STRAIN AND USE THEREOF TO TREAT OR PREVENT INFLAMMATORY DISORDERS | 2008 |
|
RU2511044C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ATTENUATED Streptococcus pneumoniae STRAINS, AND ITS APPLICATION | 2018 |
|
RU2772131C2 |
